Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the positive Verification & Validation (V&V) data for the Extended ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Guidance Management Comments

Quotient Announces Positive Verification and Validation Results for Extended Immunohematology Microarray and Updates on Hypercare Sites and Revenue Performance in the QuarterOctober 17, 2019 4:50 PM